Trademark Overview
On Wednesday, December 24, 2008, a trademark application was filed for KOGNIBON with the United States Patent and Trademark Office. The USPTO has given the KOGNIBON trademark a serial number of 77639740. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, January 28, 2009. This trademark is owned by Pfizer Inc.. The KOGNIBON trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines